Syndax Pharmaceuticals (SNDX) Current Leases (2019 - 2026)
Syndax Pharmaceuticals (SNDX) posted quarterly Current Leases of $487000.0 for Q1 2026, up 29.18% year-over-year from $377000.0 in Q1 2025, and up 3.62% quarter-over-quarter from $470000.0 in Q4 2025.
Powered by 
Analysis
Syndax Pharmaceuticals (SNDX) Current Leases (2019 - 2026) Analysis & Trends
Syndax Pharmaceuticals' Current Leases history runs 8 years deep, the most recent figure standing at $487000.0 for Q1 2026.
- In Q1 2026, Current Leases rose 29.18% year-over-year to $487000.0; the TTM figure through Mar 2026 stood at $487000.0 (up 29.18% YoY), while the FY2025 annual figure was $470000.0, changed 0.21% from the prior year.
- Current Leases for Q1 2026 stood at $487000.0, up from $470000.0 in the prior quarter.
- The five-year high for Current Leases was $1.0 million in Q1 2024, with the low at $299000.0 in Q2 2022.
- The 5-year median for Current Leases is $471000.0 (2022), against an average of $607000.0.
- The sharpest annual moves came in 2023 and 2025: Current Leases soared 220.07% in 2023, then slumped 64.93% in 2025.
- Syndax Pharmaceuticals' Current Leases stood at $434000.0 in 2022, then jumped by 138.48% to $1.0 million in 2023, then sank by 54.49% to $471000.0 in 2024, then declined by 0.21% to $470000.0 in 2025, then rose by 3.62% to $487000.0 in 2026.
- Business Quant data shows SNDX's Current Leases at $487000.0 in Q1 2026, $470000.0 in Q4 2025, and $329000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 11.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 16.75 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 21.95 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 45.93 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Syndax Pharmaceuticals | 1.83 Bn | 1.28 Bn | 60.67 Mn | 506,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 506,000.00 |
| Mar 31, 2026 | 487,000.00 |
| Dec 31, 2025 | 470,000.00 |
| Sep 30, 2025 | 329,000.00 |
| Jun 30, 2025 | 344,000.00 |
| Mar 31, 2025 | 377,000.00 |
| Dec 31, 2024 | 471,000.00 |
| Sep 30, 2024 | 842,000.00 |
| Jun 30, 2024 | 981,000.00 |
| Mar 31, 2024 | 1.04 Mn |
| Dec 31, 2023 | 1.04 Mn |
| Sep 30, 2023 | 995,000.00 |
| Jun 30, 2023 | 957,000.00 |
| Mar 31, 2023 | 454,000.00 |
| Dec 31, 2022 | 434,000.00 |
| Sep 30, 2022 | 471,000.00 |
| Jun 30, 2022 | 299,000.00 |
| Mar 31, 2022 | 331,000.00 |
| Dec 31, 2021 | 361,000.00 |
| Sep 30, 2021 | 369,000.00 |